These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 2842714)
1. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714 [TBL] [Abstract][Full Text] [Related]
2. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes. Ben-David Y; Lavigueur A; Cheong GY; Bernstein A New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628 [TBL] [Abstract][Full Text] [Related]
3. Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia. Munroe DG; Rovinski B; Bernstein A; Benchimol S Oncogene; 1988 Jun; 2(6):621-4. PubMed ID: 3290808 [TBL] [Abstract][Full Text] [Related]
4. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Moreau-Gachelin F; Tavitian A; Tambourin P Nature; 1988 Jan; 331(6153):277-80. PubMed ID: 2827041 [TBL] [Abstract][Full Text] [Related]
5. Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias. Moreau-Gachelin F; Ray D; de Both NJ; van der Feltz MJ; Tambourin P; Tavitian A Leukemia; 1990 Jan; 4(1):20-3. PubMed ID: 2153262 [TBL] [Abstract][Full Text] [Related]
6. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence. Wong KS; Li YJ; Howard J; Ben-David Y Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829 [TBL] [Abstract][Full Text] [Related]
7. Friend virus induced murine erythroleukaemia: the p53 locus. Johnson P; Benchimol S Cancer Surv; 1992; 12():137-51. PubMed ID: 1638545 [TBL] [Abstract][Full Text] [Related]
8. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia. Prasher JM; Elenitoba-Johnson KS; Kelley LL Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707 [TBL] [Abstract][Full Text] [Related]
9. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483 [TBL] [Abstract][Full Text] [Related]
11. Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. Dreyfus F; Sola B; Fichelson S; Varlet P; Charon M; Tambourin P; Wendling F; Gisselbrecht S Leukemia; 1990 Aug; 4(8):590-4. PubMed ID: 2143796 [TBL] [Abstract][Full Text] [Related]
12. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias. Howard J; Ung Y; Adachi D; Ben-David Y Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333 [TBL] [Abstract][Full Text] [Related]
13. Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. Chow V; Ben-David Y; Bernstein A; Benchimol S; Mowat M J Virol; 1987 Sep; 61(9):2777-81. PubMed ID: 3302314 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression. Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324 [TBL] [Abstract][Full Text] [Related]
15. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Moreau-Gachelin F; Ray D; Mattei MG; Tambourin P; Tavitian A Oncogene; 1989 Dec; 4(12):1449-56. PubMed ID: 2594367 [TBL] [Abstract][Full Text] [Related]
16. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage. Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822 [TBL] [Abstract][Full Text] [Related]
17. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856 [TBL] [Abstract][Full Text] [Related]
18. Sequences of polycythemia-type Friend spleen focus-forming virus in clone-745-derived mouse erythroleukemia cells. Scher W; Jing Y; Lu M; Bishop DF; Scher BM Arch Virol; 2009; 154(5):895-8. PubMed ID: 19347245 [TBL] [Abstract][Full Text] [Related]
19. Augmentation of helper virus replication in the presence of defective retrovirus. Anand R; Steeves RA; Lilly F Microbios; 1989; 58(235):71-82. PubMed ID: 2544787 [TBL] [Abstract][Full Text] [Related]
20. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Rovinski B; Benchimol S Oncogene; 1988 May; 2(5):445-52. PubMed ID: 3287278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]